Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy
J-Y Pierga(Institute of Cancer Research), Mitch Dowsett(Institute of Cancer Research), Susan Cleator(Imperial College Healthcare NHS Trust), Marjan Iravani(Institute of Cancer Research), Alan Mackay(Institute of Cancer Research), Jorge S. Reis‐Filho(AstraZeneca (France)), Kerry Fenwick(Institute of Cancer Research), Ian E. Smith(Papworth Hospital), Alan Ashworth(University of California, San Francisco), Margaret Hills(Royal Marsden NHS Foundation Trust), T.J. Powles(Royal Marsden NHS Foundation Trust), Janine Salter(Nottingham City Hospital), Chris Jones(North Carolina State University), Tim Dexter(Institute of Cancer Research), Peter T. Simpson(The University of Queensland)
Cited by 51
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
|The Lancet|2007|1.5k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)
|Archives of Pathology & Laboratory Medicine|2010|1.1k